Targeting the RNA-binding protein Sam68 as a treatment for cancer?

Area of Science:

• Molecular Biology
• Oncology
• RNA Biology

Background:

• RNA-binding proteins (RBPs) have complex roles in human diseases, including cancer.
• The signal transduction activator of RNA metabolism (STAR) family, including Sam68, is often considered tumor suppressors, but evidence is limited.
• Recent findings challenge this view, suggesting a pro-oncogenic role for Sam68.

Purpose of the Study:

• To investigate the role of the STAR protein Sam68 in cancer progression.
• To clarify whether Sam68 functions as an oncogene or a tumor suppressor.
• To evaluate Sam68 as a potential therapeutic target in cancer.

Main Methods:

• Analysis of Sam68-null mice to assess cancer predisposition and developmental defects.
• Evaluation of Sam68 haploinsufficiency in mouse models of mammary cancer (Polyoma Middle T antigen).
• Review of existing literature and data on Sam68's role in cancer.

Main Results:

• Sam68-null mice do not exhibit increased cancer susceptibility but show significant mammary gland development defects.
• Sam68 haploinsufficiency reduces mammary tumor onset and multiplicity in oncogene-induced mouse models.
• These findings suggest Sam68 actively promotes cancer progression.

Conclusions:

• Sam68's role in cancer is likely oncogenic, contradicting previous assumptions.
• Sam68 acts as a positive regulator of cancer progression, particularly in mammary tumors.
• Sam68 represents a potential therapeutic target for cancer treatment.